Kaboo R - Search Results

1

Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumor.

Figlin RA, Pierce WC, Kaboo R, Tso CL, Moldawer N, Gitlitz B, deKernion J, Belldegrun A. Figlin RA, et al. Among authors: kaboo r. J Urol. 1997 Sep;158(3 Pt 1):740-5. doi: 10.1097/00005392-199709000-00012. J Urol. 1997. PMID: 9258071 Clinical Trial.

2

In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer.

Hathorn RW, Tso CL, Kaboo R, Pang S, Figlin R, Sawyers C, deKernion JB, Belldegrun A. Hathorn RW, et al. Among authors: kaboo r. Cancer. 1994 Oct 1;74(7):1904-11. doi: 10.1002/1097-0142(19941001)74:7<1904::aid-cncr2820740713>3.0.co;2-b. Cancer. 1994. PMID: 7521786

3

The effects of granulocyte-macrophage colony-stimulating factor on tumour-infiltrating lymphocytes from renal cell carcinoma.

Steger GG, Kaboo R, deKernion JB, Figlin R, Belldegrun A. Steger GG, et al. Among authors: kaboo r. Br J Cancer. 1995 Jul;72(1):101-7. doi: 10.1038/bjc.1995.284. Br J Cancer. 1995. PMID: 7599037 Free PMC article.

4

Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivo.

Steger GG, Pierce WC, Figlin R, Czernin J, Kaboo R, DeKernion JB, Okarma T, Belldegrun A. Steger GG, et al. Among authors: kaboo r. Clin Immunol Immunopathol. 1994 Aug;72(2):237-47. doi: 10.1006/clin.1994.1137. Clin Immunol Immunopathol. 1994. PMID: 8050198

5

Interferon-alpha primed tumor-infiltrating lymphocytes combined with interleukin-2 and interferon-alpha as therapy for metastatic renal cell carcinoma.

Belldegrun A, Pierce W, Kaboo R, Tso CL, Shau H, Turcillo P, Moldawer N, Golub S, deKernion J, Figlin R. Belldegrun A, et al. Among authors: kaboo r. J Urol. 1993 Nov;150(5 Pt 1):1384-90. doi: 10.1016/s0022-5347(17)35785-3. J Urol. 1993. PMID: 8411405 Clinical Trial.

6

Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.

Belldegrun A, Tso CL, Sakata T, Duckett T, Brunda MJ, Barsky SH, Chai J, Kaboo R, Lavey RS, McBride WH, et al. Belldegrun A, et al. Among authors: kaboo r. J Natl Cancer Inst. 1993 Feb 3;85(3):207-16. doi: 10.1093/jnci/85.3.207. J Natl Cancer Inst. 1993. PMID: 8423625

7

In vivo trafficking of adoptively transferred interleukin-2 expanded tumor-infiltrating lymphocytes and peripheral blood lymphocytes. Results of a double gene marking trial.

Economou JS, Belldegrun AS, Glaspy J, Toloza EM, Figlin R, Hobbs J, Meldon N, Kaboo R, Tso CL, Miller A, Lau R, McBride W, Moen RC. Economou JS, et al. Among authors: kaboo r. J Clin Invest. 1996 Jan 15;97(2):515-21. doi: 10.1172/JCI118443. J Clin Invest. 1996. PMID: 8567975 Free PMC article.

8

Natural immune reactivity-associated therapeutic response in patients with metastatic renal cell carcinoma receiving tumor-infiltrating lymphocytes and interleukin-2-based therapy.

Belldegrun A, Tso CL, Kaboo R, Pang S, Pierce W, deKernion JB, Figlin R. Belldegrun A, et al. Among authors: kaboo r. J Immunother Emphasis Tumor Immunol. 1996 Mar;19(2):149-61. doi: 10.1097/00002371-199603000-00008. J Immunother Emphasis Tumor Immunol. 1996. PMID: 8732698 Clinical Trial.

9

Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients.

Sokoloff MH, Tso CL, Kaboo R, Nelson S, Ko J, Dorey F, Figlin RA, Pang S, deKernion J, Belldegrun A. Sokoloff MH, et al. Among authors: kaboo r. J Urol. 1996 Nov;156(5):1560-6. J Urol. 1996. PMID: 8863538 Clinical Trial.

10

Adenovirus-mediated interleukin-2 production by tumors induces growth of cytotoxic tumor-infiltrating lymphocytes against human renal cell carcinoma.

Mulders P, Tso CL, Pang S, Kaboo R, McBride WH, Hinkel A, Gitlitz B, Dannull J, Figlin R, Belldegrun A. Mulders P, et al. Among authors: kaboo r. J Immunother. 1998 May;21(3):170-80. doi: 10.1097/00002371-199805000-00002. J Immunother. 1998. PMID: 9610908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters